Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysfunction of Cellular Proteostasis in Parkinson’s Disease
Šárka Lehtonen, Tuuli-Maria Sonninen, Sara Wojciechowski, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Prodromal Parkinson disease subtypes — key to understanding heterogeneity
Daniela Berg, Per Borghammer, Seyed‐Mohammad Fereshtehnejad, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 6, pp. 349-361
Closed Access | Times Cited: 272
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
Brage Brakedal, Christian Dölle, Frank Riemer, et al.
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 396-407.e6
Open Access | Times Cited: 194
Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe, Craig M. Crews
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 934-951
Open Access | Times Cited: 186
Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 168
The emerging role of α-synuclein truncation in aggregation and disease
Zachary A. Sorrentino, Benoit I. Giasson
Journal of Biological Chemistry (2020) Vol. 295, Iss. 30, pp. 10224-10244
Open Access | Times Cited: 139
Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74
Interaction Between the Glymphatic System and α-Synuclein in Parkinson’s Disease
Yu Zhang, Cui Zhang, Xu-Zhong He, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 4, pp. 2209-2222
Closed Access | Times Cited: 59
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 56
Evolving Landscape of Parkinson’s Disease Research: Challenges and Perspectives
Rumiana Koynova, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Omega (2025) Vol. 10, Iss. 2, pp. 1864-1892
Open Access | Times Cited: 3
Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum
Tasuku Konno, Eduardo P. Melo, Joseph E. Chambers, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 233-233
Open Access | Times Cited: 93
Promising drug targets and associated therapeutic interventions in Parkinson’s disease
Sachchida Nand, Payal Singh, Ritu Varshney, et al.
Neural Regeneration Research (2021) Vol. 16, Iss. 9, pp. 1730-1730
Open Access | Times Cited: 85
The Cross-Links of Endoplasmic Reticulum Stress, Autophagy, and Neurodegeneration in Parkinson’s Disease
Haigang Ren, Wanqing Zhai, Xiaojun Lu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 71
SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 37-56
Open Access | Times Cited: 68
Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown
Mingxia Bi, Xixun Du, Qian Jiao, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 60
Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders
Nelson de Oliveira Manzanza, Lucia Sedlackova, Raj N. Kalaria
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 57
Integration of miRNA’s theranostic potential with nanotechnology: Promises and challenges for Parkinson’s disease therapeutics
Kamatham Pushpa Tryphena, Gurpreet Singh, Naitik Jain, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111800-111800
Closed Access | Times Cited: 25
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Poojitha Pinjala, Kamatham Pushpa Tryphena, Renuka Prasad, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 25
CNS Ageing in Health and Neurodegenerative Disorders
Evangelia Kesidou, Paschalis Theotokis, Olympia Damianidou, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2255-2255
Open Access | Times Cited: 24
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Wioletta Rozpędek‐Kamińska, Natalia Siwecka, Adam Wawrzynkiewicz, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2108-2108
Open Access | Times Cited: 68
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
Katherine J. Wert, Gabriel Velez, Kanchustambham Vijayalakshmi, et al.
EBioMedicine (2020) Vol. 52, pp. 102636-102636
Open Access | Times Cited: 50
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Anamaria Jurcău, Felicia Liana Andronie-Cioară, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14582-14582
Open Access | Times Cited: 22
Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis
Mayuri Khot, Anika Sood, Kamatham Pushpa Tryphena, et al.
Brain Research (2023) Vol. 1815, pp. 148462-148462
Closed Access | Times Cited: 19
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 7
Proteostasis in neurodegenerative diseases
Sumit Kinger, Yuvraj Anandrao Jagtap, Prashant Kumar, et al.
Advances in clinical chemistry (2024), pp. 270-333
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top